Eledon Pharmaceuticals share price logo

Eledon Pharmaceuticals

NASDAQ: ELDN

$2.42

as on

Eledon Pharmaceuticals Stock Performance

as on October 9, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.36
    $2.44
    downward going graph

    2.48%

    Downside

    0.83%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.35
    $4.60
    downward going graph

    44.21%

    Downside

    90.08%

    Upside

    downward going graph

Eledon Pharmaceuticals share price movements today

Previous Close
$2.42
Open
$2.40
Volume
605.4K
Market Cap
$196.7M
Day's Low - High
$2.36 - $2.44
52 Week Low - High
$1.35 - $4.60

Eledon Pharmaceuticals Historical Returns

1 Month Return
-14.18 %
3 Month Return
-41.4 %
1 Year Return
-18.79 %
3 Year Return
+ 55.13 %
5 Year Return
-59.5 %

Eledon Pharmaceuticals Stock Fundamentals & Key Indicators

Check Eledon Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$196.7M

EPS (TTM)

-0.99

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.44

Industry PE ratio

-3.09

PEG Ratio

0.00

EBITDA

-80.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-136.45%

Eledon Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eledon Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$196.7M-59.50%-2.440.00%0.00%
Neutral$78.4B-35.39%-24.62-12.57%0.00%
StrongBuy$128.2B181.24%29.1986.04%0.00%
Buy$76.1B34.46%17.7284.86%0.50%

Stock Returns calculator for Eledon Pharmaceuticals Stock including INR - Dollar returns

The Eledon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Eledon Pharmaceuticals investment value today

Current value as on today

₹88,546

Returns

-₹11,454

(-11.45%)

Returns from Eledon Pharmaceuticals Stock

-₹18,792 (-18.79%)

Dollar Impact

₹7,338 (+7.34%)

Analyst Recommendation on Eledon Pharmaceuticals Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Eledon Pharmaceuticals. Average target price of $9

Eledon Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Eledon Pharmaceuticals.

What analysts predicted

73.11%UPSIDE

Target Price

$9

Current Price

$2.42

Analyzed by

1 Analysts

High

$8

Target

$9.00

Low

$8

Eledon Pharmaceuticals target price $9, a slight upside of 73.11% compared to current price of $2.42. According to 1 analysts rating.

Indian Investors' Interest in Eledon Pharmaceuticals Stock

Search interest for Eledon Pharmaceuticals Stock has increased by 182% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:182% versus previous 30 day period

Eledon Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-10
-14
-20
-24
-17
-24
-19
-21
-21
-22
EBITDA
-23
-44
77
-44
-6
-11
-17
-10
-39
-14
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
-
-
-
0
-
-
Income Before Tax
-23
-44
76
-44
-6
-11
-17
-10
-39
-31
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-23
-44
76
-44
-6
-11
-17
-10
-39
-31
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Eledon Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
-13
-14
-14
-18
-36
-88
-43
-70
-83
EBITDA
-13
-14
-15
-16
-36
-39
-116
-35
-45
Interest Expense
-
-
-
9
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-14
-16
-23
-36
-87
-116
-35
-45
Income Tax Expense
-
0
-
0
-2
-
-
0
0
Net Income
-13
-14
-16
-22
-34
-87
-116
-36
-45
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Eledon Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
-44
63
-44
-6
-11
-17
-10
-39
-31
Operating Cash Flow
-8
-7
-11
-18
-16
-17
-14
-14
-22
-22
Investing Cash Flow
9
-19
-12
-47
3
14
12
-20
5
23
Financing Cash Flow
0
48
5
80
0
-
-
53
-
0
Change in Cash
1
20
-19
13
-12
-2
-2
19
-16
0

Eledon Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-14
-16
-22
-34
-87
-116
-36
-45
Operating Cash Flow
-14
-11
-13
-15
-28
-28
-39
-47
-62
Investing Cash Flow
23
-
-
11
-
-
-45
-70
10
Financing Cash Flow
7
7
9
109
0
-
33
133
53
Change in Cash
16
-4
-4
105
-29
-28
-51
15
2

Global Institutional Holdings in Eledon Pharmaceuticals

Check out the Institutions with significant holdings in Eledon Pharmaceuticals.

Funds
Holdings
Vanguard
4.76%
VANGUARD INDEX FUNDS
3.95%
iShares
3.74%
Fidelity Salem Street Trust
1.04%
Fidelity Concord Street Trust
0.86%

Eledon Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 07 November

    Fri, 07:20 PM

    -

    Eledon Pharmaceuticals stock drops 52.2% after Phase 2 trial fails to meet primary endpoint for tegoprubart.

    Sat, 00:06 AM

    -

    Despite Phase 2 failure, Eledon plans to advance tegoprubart into Phase 3 development.

Insights on Eledon Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 93.4% return, outperforming this stock by 38.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 615.6% return, outperforming this stock by 634.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ELDN stock has moved down by -41.4%

About Eledon Pharmaceuticals

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.
OrganisationEledon Pharmaceuticals
Headquarters19900 MacArthur Boulevard, Irvine, CA, 92612, US
IndustryBiotechnology
CEODavid-Alexandre C. Gros

Key Management of Eledon Pharmaceuticals

Name

Title

Dr. Sepideh Habibi

VP and Head of Safety & Pharmacovigilance

Dr. David-Alexandre C. Gros M.D., Ph.D.

CEO & Non Independent Director

Dr. Steven N. Perrin Ph.D.

President, Chief Scientific Officer & Non Independent Director

Mr. Paul Sean Little

Chief Financial Officer

Mr. John Herberger

Vice President of Technical Operations

Mr. Bryan E. Smith J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Dr. David Hovland Ph.D.

Chief Regulatory Officer

Ms. Marina Escudero

VP & Head of Clinical Operations

FAQs

What is Eledon Pharmaceuticals share price today?

Eledon Pharmaceuticals share price today is $2.42 as on at the close of the market. Eledon Pharmaceuticals share today touched a day high of $2.44 and a low of $2.36.

What is the 52 week high and 52 week low for Eledon Pharmaceuticals share?

Eledon Pharmaceuticals share touched a 52 week high of $4.60 on and a 52 week low of $1.35 on . Eledon Pharmaceuticals stock price today i.e. is closed at $2.42,which is 47.39% down from its 52 week high and 79.26% up from its 52 week low.

What is Eledon Pharmaceuticals's market capitalisation today?

Eledon Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Eledon Pharmaceuticals Stock (ELDN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eledon Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Eledon Pharmaceuticals Stock (ELDN) from India?

Indian investors can start investing in Eledon Pharmaceuticals (ELDN) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Eledon Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Eledon Pharmaceuticals share’s latest price of $2.42 as on October 9, 2026 at 8:46 am IST, you will get 4.1322 shares of Eledon Pharmaceuticals. Learn more about fractional shares .

What are the returns that Eledon Pharmaceuticals has given to Indian investors in the last 5 years?

Eledon Pharmaceuticals stock has given -59.5% share price returns and 28.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?